Brian J. Lyngaas, D.D.S., P.L.L.C. v. IQVIA, INC.

CourtDistrict Court, E.D. Pennsylvania
DecidedJuly 9, 2024
Docket2:20-cv-02370
StatusUnknown

This text of Brian J. Lyngaas, D.D.S., P.L.L.C. v. IQVIA, INC. (Brian J. Lyngaas, D.D.S., P.L.L.C. v. IQVIA, INC.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brian J. Lyngaas, D.D.S., P.L.L.C. v. IQVIA, INC., (E.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

BRIAN J. LYNGAAS, D.D.S., : CIVIL ACTION P.L.L.C. : Plaintiff : NO. 21-1334 : NO. 20-2370 v. : : IQVIA, INC. : Defendant :

NITZA I. QUIÑONES ALEJANDRO, J. JULY 9, 2024

MEMORANDUM OPINION

INTRODUCTION Plaintiff Brian J. Lyngaas, D.D.S., P.L.L.C. (“Plaintiff”) filed this class action against Defendant IQVIA, Inc. (“Defendant”), asserting that Defendant violated the Telephone Consumer Protection Act (the “TCPA”), 47 U.S.C. § 227(b)(1)(C), when sending Plaintiff and other purportedly similarly situated healthcare provider class members unsolicited fax advertisements without prior express invitation or permission. (ECF 1). Before this Court is Plaintiff’s motion for class certification filed pursuant to Federal Rule of Civil Procedure (“Rule”) 23, (ECF 106, 118), and Defendant’s response in opposition, (ECF 112, 115).1 On February 28, 2024, a hearing on the motion for class certification was held.2 Following the class certification hearing (the “hearing”), the parties submitted additional post- hearing briefing. (ECF 158–61). The motion for class certification is now ripe for disposition. For the reasons set forth, the motion for class certification is denied.

1 This Court has also considered Plaintiff’s reply, (ECF 125, 127).

2 The transcript of this hearing is cited throughout as “Hearing Tr.” BACKGROUND The TCPA provides that “[i]t shall be unlawful for any person within the United States, or any person outside the United States if the recipient is within the United States . . . to use any telephone facsimile machine, computer, or other device to send, to a telephone facsimile machine,

an unsolicited advertisement.” 47 U.S.C. § 227(b)(1)(C). Under the TCPA, an “unsolicited advertisement” is “any material advertising the commercial availability or quality of any property, goods, or services which is transmitted to any person without that person’s prior express invitation or permission, in writing or otherwise.” Id. at § 227(a)(5). Here, Plaintiff asserts that Defendant violated the TCPA by faxing mass advertisements to Plaintiff and a class of purportedly more than 150,000 healthcare providers without obtaining prior express invitation or permission. The facts relevant to the class certification are summarized as follows:3 Plaintiff is a dental practice in Livonia, Michigan. Defendant is a global provider of information, innovative technology solutions, and contract research services, previously known as IMS Health.

As background, on August 12, 2010, SK&A Information Services (“SK&A”)4 entered into a license agreement with its client, ImpactRx, to use certain healthcare provider data for the following permitted use:

Direct marketing to the mailing addresses, telephone numbers, and fax numbers of recipients included in the Licensed Information an unlimited number of times during the SOW Term [a one-year duration beginning on August 12, 2010].

(ECF 117-14, Ex. 38 at p. 2). The licensed data included SK&A’s database consisting of healthcare providers who had completed telephone surveys. Each conducted survey call had the objective “to verify . . . information [including their name and fax number] and to reobtain permission from the healthcare professional

3 The facts are derived from the parties’ statements of fact, briefs, the exhibits attached thereto, and the evidence presented at the hearing.

4 Neither party provides a description of what kind of company SK&A is. for the inclusion . . . of their data in . . . Defendant’s products.”5 (Escalante Dep., ECF 116-9, Ex. 10 at 57:16–25).

On April 1, 2015, Defendant acquired SK&A. During the summer of 2016, the companies “trade[d] assets,” including SK&A’s telephone verified database, “without a documentation trail.” (Id. at 110:18–25; 115:21–126:06). Defendant licensed the data from SK&A “with the expectation” that it could be used to send faxes to the healthcare providers. (Snyder Dep., ECF 116-15, Ex. 17 at 125:13– 19). Sometime in 2016, Defendant acquired ImpactRx, a client of SK&A.

When this action was filed in 2020, three of Defendant’s datasets containing a portion of those healthcare providers’ contact information existed and included approximately 9,824 fax numbers of various healthcare providers who “verified and gave permission to include their fax number” in the SK&A database. (Escalante Dep., ECF 116-9, Ex. 10 at 149:18–150:01); (Deal Rep., ECF 116-3, Ex. 4 at ¶ 30).

During the relevant time period (after May 19, 2016), Defendant administered a research study called the National Healthcare Census (the “NHC”) to “measure the over-the-counter recommendations of healthcare professionals.” (Cortright Dep., ECF 116-7, Ex. 8 at 20:08–12). To conduct the survey, Defendant engaged third-party Odyssey Services, Inc. (“Odyssey”) to send faxes regarding the NHC study to healthcare professionals. The NHC faxes invited healthcare providers to register and complete the research study online. Defendant provided honorariums ranging from $15 to $150 to those healthcare providers who participated in the study. As part of the agreement between Odyssey and Defendant, Odyssey emailed Defendant documents referred to as “reports about the fax jobs” (the “Job Reports”), (Cortright Dep., ECF 116-7, Ex. 8 at 67:18–19), and its invoices for payment.

Sometime in September 2018, Odyssey suffered a ransomware attack that erased all of its records, including the records Odyssey had previously sent on Defendant’s behalf during the purported class period. (Lokaisingh Dep., ECF 113- 14, Ex. 14 at 56:08–20). Due to this ransomware attack, Odyssey was unable to produce any records in this case. Instead, Defendant produced the Job Reports which were located in email and network files of certain employees. (Cortright Dep., ECF 116-7, Ex. 8 at 71:03–05).

5 In a “statement of work,” SK&A provided, “Client acknowledges that IMS [SK&A] has not solicited or obtained the prior affirmative consent of any person whose information is included in the Licensed Information to receive communications whether of a commercial or non-commercial nature from or on behalf of Client.” (Escalante Dep., ECF 118-8, Ex. 7 at p. 96). In 2016, SK&A’s website warned that “SK&A does not obtain permission from healthcare sites or individual contacts to send communications to such fax numbers. SK&A’s fax services are not offered to support unsolicited commercial advertisements.” (ECF 106-10, Ex. I at p. 6). Plaintiff claims that he received unsolicited faxes from Defendant regarding the NHC study on February 10, 2017, June 13, 2017, August 3, 2017, and August 8, 2017.

Based on these allegations, Plaintiff moves to certify the purported class defined as: All persons: (1) who were sent one or more facsimiles between September 29, 2016 and August 28, 2018, inviting them to participate in Impact Network’s “National Healthcare Census” in exchange for monetary payment; (2) who did not participate in and had never participated in the “National Healthcare Census” survey; and (3) as to whom Defendant has not produced evidence showing SK&A verified the person’s fax number.

(Pl’s. Mot., ECF 118, at p. 20). LEGAL STANDARD Rule 23 governs the certification of class actions in federal court. A plaintiff seeking class certification must satisfy all requirements of Rule 23(a) and at least one of the requirements of Rule 23(b). Amgen Inc. v. Conn. Ret. Plans & Tr. Funds, 568 U.S. 455, 465 (2013); see also Marcus v. BMW of N.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Marcus v. BMW of North America, LLC
687 F.3d 583 (Third Circuit, 2012)
William Hayes v. WalMart Stores Inc
725 F.3d 349 (Third Circuit, 2013)
Gabriel Carrera v. Bayer Corp
727 F.3d 300 (Third Circuit, 2013)
In Re Hydrogen Peroxide Antitrust Litigation
552 F.3d 305 (Third Circuit, 2009)
Crystal Byrd v. Aaron's Inc
784 F.3d 154 (Third Circuit, 2015)
In re: Lamictal Direct Purchas v.
957 F.3d 184 (Third Circuit, 2020)
Blades v. Monsanto Co.
400 F.3d 562 (Eighth Circuit, 2005)
Jarzyna v. Home Properties, L.P.
321 F.R.D. 237 (E.D. Pennsylvania, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Brian J. Lyngaas, D.D.S., P.L.L.C. v. IQVIA, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/brian-j-lyngaas-dds-pllc-v-iqvia-inc-paed-2024.